|
|
Living Kidney Donation Relatively Safe - Renal and Urology News |
July 02, 2015
Ongoing study suggests that renal function continues to increase after donation but decreases in donation-eligible controls.
Living kidney donors exhibit some findings of mild chronic kidney disease (CKD) from 6 to 36 months post-donation, according to a recently published study. At 36 months, however, kidney function continues to improve in donors, whereas controls eligible for kidney donation experience expected age-related declines in function, researchers concluded.
“We've always assumed that living kidney donation is safe, and it is, but safety is a relative thing,” said lead investigator Bertram L. Kasiske, MD, of the Hennepin County Medical Center and University of Minnesota in Minneapolis. “There have not been the long-term studies with suitable controls that we need to prove the safety of living kidney donation over time.”
The study compared living kidney donors with a control group of individuals who met eligibility criteria for kidney donation at the donors' transplant center, but did not undergo renal imaging or invasive testing. The investigators obtained medical histories, vital signs, measured glomerular filtration rate (mGFR), and other measurements at 6, 12, 24, and 36 months after donation.
The 2 groups differed significantly in the change in mGFR after donation. From 6 to 36 months, mean mGFR, as measured by plasma iohexol clearance, increased by 1.09 mL/min/1.73 m2 per year among 198 donors but declined by 0.44 mL/min/1.73 m2 per year among 194 controls, Dr. Kasiske's group reported online ahead of print in the American Journal of Kidney Diseases. Blood pressure (BP) measurements did not differ between donors and controls at any visit; at 36 months, all 24-hour ambulatory BP parameters were similar in 126 controls and 135 donors. Urinary protein-creatinine and albumin-creatinine ratios were not increased in donors versus controls. Compared with controls, donors at 6 to 36 months had higher serum parathyroid hormone, uric acid, homocysteine, and potassium levels and lower hemoglobin levels. These abnormalities could portend a higher risk of fractures or bone problems later in life, Dr. Kasiske said, and elevated uric acid levels coincide with reports of increased rates of gout in some kidney donors.
At 36 months, 183 (89.7%) of the 203 original donors and 173 (86.1%) of the original controls continue to participate in follow-up visits.
|
|
|
DaVita Kidney Care Shares Kidney-Friendly Fourth of July Recipes for Dialysis ... - SYS-CON Media (press release) |
 <![CDATA[ <!-- /* Style Definitions */ span.prnews_span { font-size:8pt; font-family:"Arial"; color:black; } a.prnews_a { color:blue; } li.prnews_li { font-size:8pt; font-family:"Arial"; color:black; } p.prnews_p { font-size:0.62em; font-family:"Arial"; color:black; margin:0in; } --> ]]>
DENVER, July 2, 2015 /PRNewswire/ -- DaVita Kidney Care, a division of DaVita HealthCare Partners Inc. (NYSE: DVA) and a leading provider of kidney care services, offers recipes that can help people with chronic kidney disease (CKD) maintain a healthy diet during the Fourth of July weekend.
"Our recipes aim to make it possible for those with kidney disease to continue their kidney-friendly eating plan even during the holidays," said Sara Colman, DaVita Kidney Care dietitian and nutrition manager for DaVita.com. "The recipes we have compiled online and in our cookbooks include fresh ingredients with a balance of healthy proteins and produce to help keep people with CKD nourished and satisfied all summer long."
DaVita's most recent cookbook, Today's Kidney Diet: Healthy Summertime Recipes, features 16 kidney-friendly meals that contain less sodium, phosphorus and potassium. It also includes hydration and thirst-control suggestions, food-safety advice and tips for eating out while on vacation.
The cookbook can be downloaded for free at DaVita.com/Cookbook. More than 900 kidney-friendly recipes, including many that are perfect for barbecues and potlucks, can be accessed at DaVita.com/Recipes. Recipes include:
About DaVita Kidney Care
DaVita Kidney Care is a division of DaVita HealthCare Partners Inc., a Fortune 500® company that, through its operating divisions, provides a variety of health care services to patient populations throughout the United States and abroad. A leading provider of dialysis services in the United States, DaVita Kidney Care treats patients with chronic kidney failure and end stage renal disease. DaVita Kidney Care strives to improve patients' quality of life by innovating clinical care, and by offering integrated treatment plans, personalized care teams and convenient health-management services. As of March 31, 2015, DaVita Kidney Care operated or provided administrative services at 2,197 outpatient dialysis centers located in the United States serving approximately 174,000 patients. The company also operated 93 outpatient dialysis centers located in 10 countries outside the United States. DaVita Kidney Care supports numerous programs dedicated to creating positive, sustainable change in communities around the world. The company's leadership development initiatives and social responsibility efforts have been recognized by Fortune, Modern Healthcare, Newsweek and WorldBlu. For more information, please visit DaVita.com.
DaVita and DaVita HealthCare Partners are trademarks or registered trademarks of DaVita HealthCare Partners Inc.
CIO, CTO & Developer Resources
Contact Information
Media:
Elizabeth Young
(303) 876-2855
[email protected]
Logo - http://photos.prnewswire.com/prnh/20140318/DC85712LOGO
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/davita-kidney-care-shares-kidney-friendly-fourth-of-july-recipes-for-dialysis-patients-300107973.html
SOURCE DaVita Kidney Care
|
|
Analyst Price Target Update on Rockwell Medical, Inc. - Money Flow Index |
|
Rockwell Medical, Inc. (NASDAQ:RMTI): 4 Brokerage firm Analysts have agreed with the mean estimate for the short term price target of $16.25 in Rockwell Medical, Inc. (NASDAQ:RMTI). However, the stock price could fluctuate by $ 9.18 from the estimate as it is suggested by the standard deviation reading. The higher estimate has been put at $26 price target with the lower price estimate is calculated at $4
As much as 4 analysts have advised buy on Rockwell Medical, Inc. (NASDAQ:RMTI) with an average broker rating of 2. Research Analysts at Zacks has the shares a rating of 3, which implies that the firms recommendation is Neutral on the company. Rockwell Medical, Inc. (NASDAQ:RMTI) : On Wednesday heightened volatility was witnessed in Rockwell Medical, Inc. (NASDAQ:RMTI) which led to swings in the share price. The shares opened for trading at $16.38 and hit $17.01 on the upside , eventually ending the session at $16.23, with a gain of 0.68% or 0.11 points. The heightened volatility saw the trading volume jump to 907,661 shares. The 52-week high of the share price is $18.04 and the company has a market cap of $814 million. The 52-week low of the share price is at $8.095 .
The company shares have rallied 34.86% from its 1 Year high price. On Jun 25, 2015, the shares registered one year high at $18.04 and the one year low was seen on Dec 15, 2014. The 50-Day Moving Average price is $12.20 and the 200 Day Moving Average price is recorded at $10.74. Rockwell Medical, Inc., formerly Rockwell Medical Technologies, Inc., manufactures hemodialysis concentrate solutions and dialysis kits, and it sells, distributes and delivers these and other ancillary hemodialysis products primarily to hemodialysis providers in the United States, as well as internationally primarily in Asia, Latin America and Europe. Hemodialysis duplicates kidney function in patients with failing kidneys also known as End Stage Renal Disease (ESRD). ESRD is an advanced-stage of chronic kidney disease (CKD) characterized by the irreversible loss of kidney function. Its dialysis solutions (also known as dialysate) are used to maintain life, removing toxins and replacing nutrients in the dialysis patients bloodstream. As of December 31, 2011, it was licensed and was developing renal drug therapies. During the year ended December 31, 2011, it acquired an abbreviated new drug application (ANDA) for a generic version of an intravenous Vitamin-D analogue, calcitriol.
|
|
Dialysis waste dumped at Michigan City recycling site - nwitimes.com |
|
A Good Samaritan Act for Dialysis Patients - The New Indian Express |
|
By Deepthi Sreenivasan
Published: 02nd July 2015 06:06 AM
Last Updated: 02nd July 2015 06:06 AM
|
|
|
|
|
<< Start < Prev 61 62 63 64 65 66 67 68 69 70 Next > End >>
|
|
Page 68 of 2630 |
Log in to explore the world's most comprehensive database of dialysis centres for free! 
Professional dialysis recruitment
